Professor Alastair Denniston is Executive Director of CERSI-AI, and is an expert in the evaluation, regulation and implementation of AI health technologies. He is a doctor in the NHS (consultant ophthalmologist at University Hospitals Birmingham) and a Professor in Regulatory Science and Innovation at the University of Birmingham, where he leads a research team, many of whom are supporting CERSI-AI. He is also Chair of the National Commission in Regulation of AI in Healthcare, a Member of the UK Government’s Regulatory Horizons Council and is Non-Executive Director to the UK’s Health Research Authority. He was a co-founder of INSIGHT, the UK’s Health Data Research Hub for Eye Health. He is passionate about supporting innovation in advanced digital and AI health technologies to accelerate the development of products that are effective, safe, and equitable, and that make a difference to people in the ‘real world’.

Improving scientific standards – developing internationally adopted reporting guidelines for clinical trials of AI health technologies: SPIRIT-AI and CONSORT-AI; and contributing to other AI reporting standards including TRIPOD+AI, STARD-AI, and DECIDE-AI.

Improving evidence – building evidence standards for digital health technologies for NICE (DHT-ESF), in collaboration with Imperial College London and the Alan Turing Institute.

Improving safety – developing tools for assessing safety of AI-enabled medical devices: the medical algorithmic audit, and through working directly with medical device regulators such as the MHRA.

Improving diversity and representation within the data used in AI – tackling bias in health datasets to mitigate AI-driven health inequalities through STANDING Together.

The group works in collaboration with academic, industry and policy institutions around the world, bringing diverse and interdisciplinary teams together to build best practices that can be translated internationally.